Sino-Argi Leading Biosciences Capital Reinvestment Ratio
Sino-Argi Leading Biosciences capital reinvestment ratio. Sino-Argi Leading Biosciences (603970) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥702.54 Million) in capital expenditures (CN¥139.59K). Check Sino-Argi Leading Biosciences total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sino-Argi Leading Biosciences (2012–2024)
Capital reinvestment ratio of Sino-Argi Leading Biosciences from 2012 to 2024. This chart tracks Sino-Argi Leading Biosciences's Capital Reinvestment Ratio across 10 annual periods. Also explore 603970 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Sino-Argi Leading Biosciences Capital Reinvestment Ratio by Year (2012–2024)
Sino-Argi Leading Biosciences capital reinvestment ratio by year from 2012 to 2024. For the full cash flow conversion analysis, see 603970 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | CN¥307.40 Million | CN¥2.18 Million | ▲ +217.1% |
| 2022 | 0.00x | CN¥1.54 Billion | CN¥3.44 Million | ▼ -81.7% |
| 2021 | 0.01x | CN¥325.42 Million | CN¥3.99 Million | ▼ -71.2% |
| 2020 | 0.04x | CN¥352.12 Million | CN¥14.99 Million | ▲ +248.8% |
| 2019 | 0.01x | CN¥218.90 Million | CN¥2.67 Million | ▼ -91.1% |
| 2018 | 0.14x | CN¥65.69 Million | CN¥8.99 Million | ▲ +28.2% |
| 2017 | 0.11x | CN¥518.83 Million | CN¥55.39 Million | ▼ -55.9% |
| 2016 | 0.24x | CN¥152.22 Million | CN¥36.85 Million | ▲ +58.5% |
| 2014 | 0.15x | CN¥40.41 Million | CN¥6.17 Million | ▲ +862.2% |
| 2012 | 0.02x | CN¥109.43 Million | CN¥1.74 Million | — |